Mice lacking alpha-synuclein are resistant to mitochondrial toxins

Neurobiology of Disease

Volumn 21, Issue 3, 2006, Pages 541-548

  Klivenyi, Peter ^a   Siwek, Donald ^b,c   Gardian, Gabrielle ^a   Yang, Lichuan ^a   Starkov, Anatoly ^a   Cleren, Carine ^a   Ferrante, Robert J ^b,c   Kowall, Neil W ^b,c   Abeliovich, Asa ^d   Beal, M Flint ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

3 Nitropropionic acid; DHBA; Malonate; MPP + levels; MPP+; MPTP; Paraquat; Vesicular uptake

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROPROPIONIC ACID; ALPHA SYNUCLEIN; DOPAMINE TRANSPORTER; MALONIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; IMMUNOCOMPETENT CELL; MOUSE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; ANIMALS; MALONATES; MICE; MICE, MUTANT STRAINS; MITOCHONDRIA; NEURONS; NEUROTOXINS; NITRO COMPOUNDS; PARKINSONIAN DISORDERS; PROPIONIC ACIDS;

EID: 33244460534     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.08.018     Document Type: Article

References (52)

1. A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-Lundberg, W.H. Ho, P.E. Castillo, N. Shinsky, J.M. Verdugo, M. Armanini, A. Ryan, M. Hynes, H. Phillips, D. Sulzer, and A. Rosenthal Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 2000 239 252
2. O.A. Andreassen, A. Dedeoglu, R.J. Ferrante, B.G. Jenkins, K.L. Ferrante, M. Thomas, A. Friedlich, S.E. Browne, G. Schilling, D.R. Borchelt, S.M. Hersch, C.A. Ross, and M.F. Beal Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease Neurobiol. Dis. 8 2001 479 491
3. O. Arrigon, and T. Singer Limitations of the phenazine methosulfate assay for succinic and related dehydrogenases Nature 193 1962 1256 1258
4. M.F. Beal Experimental models of Parkinson's disease Nat. Rev., Neurosci. 2 2001 325 334
5. M.F. Beal, E. Brouillet, B. Jenkins, R. Henshaw, B. Rosen, and B.T. Hyman Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J. Neurochem. 61 1993 1147 1150
6. R. Betarbet, R.H. Porter, and J.T. Greenamyre GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation J. Neurochem. 74 2000 1166 1174
7. E. Brouillet, and P. Hantraye Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates Curr. Opin. Neurol. 8 1995 469 473
8. L. Chen, and M.B. Feany alpha-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson's disease Nat. Neurosci. 8 2005 657 663
9. D.F. Clayton, and J.M. George Synucleins in synaptic plasticity and neurodegenerative disorders J. Neurosci. Res. 58 1999 120 129
10. N.B. Cole, and D.D. Murphy The cell biology of a-synuclein NeuroMolec. Med. 1 2002 95 109
11. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. U. S. A. 97 2000 571 576
12. K.A. Conway, J.C. Rochet, R.M. Bieganski, and P.T. Lansbury Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine- alpha-synuclein adduct Science 294 2001 1346 1349
13. W. Dauer, N. Kholodilov, M. Vila, A.C. Trillat, R. Goodchild, K.E. Larsen, R. Staal, K. Tieu, Y. Schmitz, C.A. Yuan, M. Rocha, V. Jackson-Lewis, S. Hersch, D. Sulzer, S. Przedborski, R. Burke, and R. Hen Resistance of a-synuclein null mice to the parkinsonsian neurotoxin MPTP Proc. Natl. Acad. Sci. U. S. A. 99 2002 14524 14529
14. R.E. Drolet, B. Behrouz, K.J. Lookingland, and J.L. Goudreau Mice lacking a-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration NeuroToxicology 25 2004 761 769
15. M.B. Feany, and W.W. Bender A Drosophila model of Parkinson's disease Nature 404 2000 298 394
16. P.O. Fernagut, E. Diguet, M. Jaber, B. Bioulac, and F. Tison Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage Eur. J. Neurosci. 15 2002 2053 2056
17. G. Forloni, I. Bertani, A.M. Calella, F. Thaler, and R. Invernizzi Alpha-synuclein and Parkinson's disease: selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo Ann. Neurol. 47 2000 632 640
18. F. Fornai, O.M. Schulter, P. Lenzi, M. Gesi, R. Ruffoli, M. Ferrucci, G. Lazzeri, C.L. Busceti, F. Pontarelli, G. Battaglia, A. Pellegrini, F. Nicoletti, S. Ruggieri, A. Paparelli, and T.C. Sudhof Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiqutin-proteasome system and a-synuclein Proc. Natl. Acad. Sci. 102 2004 3413 3418
19. R.A. Furlong, Y. Narain, J. Rankin, A. Wyttenbach, and D.C. Rubinsztein alpha-synuclein overexpression promotes aggregation of mutant huntingtin Biochem. J. 346 2000 577 581
20. B.I. Giasson, J.E. Duda, I.V. Murray, Q. Chen, J.M. Souza, H.I. Hurtig, H. Ischiropoulos, J.Q. Trojanowski, and V.M. Lee Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
21. B.I. Giasson, J.E. Duda, S.M. Quinn, B. Zhang, J.Q. Trojanowski, and V.M. Lee Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 2002 521 533
22. M. Goedert Alpha-synuclein and neurodegenerative diseases Nat. Rev., Neurosci. 2 2001 492 501
23. L.J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, M. Mallory, J. Wong, T. Takenouchi, M. Hashimoto, and E. Masliah α-Synuclein promotes mitochondrial deficit and oxidative stress Am. J. Pathol. 157 2000 401 410
24. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, A. Schindzielorz, M. Okochi, U. Leimer, H. van Der Putten, A. Probst, E. Kremmer, H.A. Kretzschmar, and C. Haass Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain J. Neurosci. 20 2000 6365 6373
25. D. Kirik, B. Georgievska, C. Burger, C. Winkler, N. Muzyczka, R.J. Mandel, and A. Bjorklund Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of l-DOPA using rAAV-mediated gene transfer Proc. Natl. Acad. Sci. U. S. A. 99 2002 4708 4713
26. P. Klivenyi, O.A. Andreassen, R.J. Ferrante, A. Dedeoglu, G. Mueller, E. Lancelot, M. Bogdanov, J.K. Andersen, D. Jiang, and M.F. Beal Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine J. Neurosci. 20 2000 1 7
27. L. Ko, N.D. Mehta, M. Farrer, C. Easson, J. Hussey, S. Yen, J. Hardy, and S.H. Yen Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein J. Neurochem. 75 2000 2546 2554
28. N.W. Kowall, P. Hantraye, E. Brouillet, M.F. Beal, A.C. McKee, and R.J. Ferrante MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons NeuroReport 11 2000 211 213
29. R. Kruger, A.M. Vieira-Saecker, W. Kuhn, D. Berg, T. Muller, N. Kuhnl, G.A. Fuchs, A. Storch, M. Hungs, D. Woitalla, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype Ann. Neurol. 45 1999 611 617
30. F.J. Lee, F. Liu, Z.B. Pristupa, and H.B. Niznik Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB J. 15 2001 916 926
31. M. Lee, D.H. Hyun, B. Halliwell, and P. Jenner Effect of the overexpression of wild-type or mutant a-synuclein on cell susceptibility to insult J. Neurochem. 76 2001 998 1009
32. A.B. Manning-Bog, A.L. McCormack, J. Li, V.N. Uversky, A.L. Fink, and D.A. Di Monte The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein J. Biol. Chem. 377 2002 1641 1644
33. W.F. Maragos, R.J. Jakel, Z. Pang, and J.W. Geddes 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions Exp. Neurol. 154 1998 637 644
34. E. Mezey, Z.E. Toth, D.N. Cortright, M.K. Arzubi, J.E. Krause, R. Elde, A. Guo, P.M. Blumberg, and A. Szallasi Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc. Natl. Acad. Sci. U. S. A. 97 2000 3655 3660
35. D.D. Murphy, S.M. Rueter, J.Q. Trojanowski, and V.M. Lee Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons J. Neurosci. 20 2000 3214 3220
36. M. Orth, S.J. Tabrizi, C. Tomlinson, K. Messmer, L.V.P. Korlipara, A.H.V. Schapira, and J.M. Cooper G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage Neurochem. Int. 45 2004 669 676
37. N. Ostrerova-Golts, L. Petrucelli, J. Hardy, J.M. Lee, M. Farer, and B. Wolozin The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity J. Neurosci. 20 2000 6048 6054
38. E. Paxinou, Q. Chen, M. Weisse, B.I. Giasson, E.H. Norris, S.M. Rueter, J.Q. Trojanowski, V.M. Lee, and H. Ischiropoulos Induction of a-synuclein aggregation by intracellular nitrative insult J. Neurosci. 21 2001 8053 8061
39. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
40. D.S. Reynolds, R.J. Carter, and A.J. Morton Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease J. Neurosci. 18 1998 10116 10127
41. E.K. Richfield, M.J. Thiruchelvam, D.A. Cory-Slechta, C. Wuertzer, R.R. Gainetdinov, M.G. Caron, D.A. DiMonte, and H.J. Federoff Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice Exp. Neurol. 175 2002 35 48
42. J.B. Schulz, D.R. Henshaw, U. MacGarvey, and M.F. Beal Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity Neurochem. Int. 29 1996 167 171
43. J.M. Souza, B.I. Giasson, Q. Chen, V.M. Lee, and H. Ischiropoulos Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies J. Biol. Chem. 275 2000 18344 18349
44. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 1998 6469 6473
45. P.G. Sullivan, N.B. Dragicevic, J.H. Deng, Y. Bai, E. Dimayuga, Q. Ding, Q. Chen, A.J. Bruce-Keller, and J.N. Keller Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover J. Biol. Chem. 279 2004 20699 20707
46. D. Sulzer, J. Bogulavsky, K.E. Larsen, G. Behr, E. Karatekin, M.H. Kleinman, N. Turro, D. Krantz, R.H. Edwards, L.A. Greene, and L. Zecca Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles Proc. Natl. Acad. Sci. U. S. A. 97 2000 11869 11874
47. S.J. Tabrizi, M. Orth, J.M. Wilkinson, J.W. Taanman, T.T. Warner, J.M. Cooper, and A.H. Schapira Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity Hum. Mol. Genet. 9 2000 2683 2689
48. N. Takahashi, L.L. Miner, I. Sora, H. Ujike, R.S. Revay, V. Kostic, V. Jackson-Lewis, S. Przedborski, and G.R. Uhl VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity Proc. Natl. Acad. Sci. U. S. A. 94 1997 9938 9943
49. P.H. Tu, J.E. Galvin, M. Baba, B. Giasson, T. Tomita, S. Leight, S. Nakajo, T. Iwatsubo, J.Q. Trojanowski, and V.M. Lee Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein Ann. Neurol. 44 1998 415 422
50. M. Vila, S. Vukosavic, V. Jackson-Lewis, M. Neystat, M. Jakowec, and S. Przedborski Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP J. Neurochem. 74 2000 721 729
51. X.G. Xia, N. Schmidt, P. Teismann, B. Ferger, and J.B. Schulz Dopamine mediates striatal malonate toxicity via dopamine transporter- dependent generation of reactive oxygen species and D2 but not D1 receptor activation J. Neurochem. 79 2001 63 70
52. J. Xu, S.Y. Kao, F.J. Lee, W. Song, L.W. Jin, and B.A. Yanker Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson's disease Nat. Med. 8 2002 600 606